For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on November 7th, 2024 | 07:15 CET
TUI, Evotec, BioNxt Solutions: Short squeeze potential, Price drops, and Momentum
BioNxt Solutions' stock has gained 50% since the end of August. The chances are good that the momentum will continue for the biotech company. The stock would need to more than double to reach its January level. The industry environment is favorable, the news flow is positive, and takeover speculation exists. Takeover speculation is perhaps the only positive factor for Evotec's share at the moment. The operational development is certainly not. Yesterday, the Company reported a significant drop in earnings. Is there any improvement in sight? Operationally, TUI has been doing well for quite some time. With a jump in the share price, the stock is now setting its sights on the resistance at EUR 8. Could there even be a short squeeze? Analysts may also shift to the bull camp.
Read
Commented by Fabian Lorenz on November 6th, 2024 | 07:35 CET
Soaring share prices, battery revolution, sales record! BYD, Plug Power and Altech Advanced Materials shares!
Altech Advanced Materials is getting ever closer to the battery revolution. And it is all happening in Germany! The prototype of their revolutionary solid-state battery is operational, and there is an initial declaration of intent in the three-digit million-euro range. The Company is valued at around EUR 25 million, providing solid reasons for a potential rapid 50% price increase. Meanwhile, Plug Power's stock has shot up a good 20% since Friday. Is this just a blip, or is there more to it for the former hydrogen high-flyer? In any case, Plug shareholders should be cautious next week. There is also a lot to be said for rising prices at BYD. The Chinese electric carmaker is in a thrilling race with Tesla for industry leadership, and analysts are forecasting over a 20% upside potential.
Read
Commented by Fabian Lorenz on November 1st, 2024 | 07:00 CET
Takeover fever and buy recommendation! Evotec, Nel ASA, Barrick Gold, Desert Gold
A hot takeover candidate in the gold sector is Desert Gold. Gold production in West Africa is expected to start in 2025. It is quite possible that one of the major gold companies will make a move by then. After the disappointing quarterly figures from Barrick Gold and Newmont calls for takeovers are growing louder. Analysts see significant upside potential. In the biotech sector, Evotec is repeatedly being discussed as a takeover candidate. The core business is considered extremely attractive, and the new CEO is expected to eliminate all the legacy issues this year. Next week will be exciting! And then there is Nel. Operationally, things are not going well for the former hydrogen star. Can the collaboration with a potential buyer turn things around?
Read
Commented by Fabian Lorenz on October 31st, 2024 | 07:00 CET
Siemens Energy unstoppable! BYD in a trade war? First Hydrogen share set for a price jump?
More and more analysts are suggesting it might be time to sell Siemens Energy stock. After all, the share is one of the top performers this year, with a price gain of more than 200%. What are the arguments in favour of selling? In contrast, anti-cyclical investors could add First Hydrogen shares to their portfolios. With plans to roll out hydrogen solutions for commercial vehicles across Europe, First Hydrogen's stock appears to have stabilized and represents the new generation in the hydrogen sector. Meanwhile, BYD is growing strongly. The Chinese are aiming for an aggressive expansion in Europe, but what do the new punitive tariffs mean? Is a trade war looming?
Read
Commented by Fabian Lorenz on October 30th, 2024 | 07:30 CET
Share about to jump? Rheinmetall, JinkoSolar, Almonty Industries
The German government has allocated EUR 1 billion for a new raw materials fund. This will enable the KfW to participate in mining projects in Germany and abroad and secure Germany's supply of critical raw materials. To reduce dependence on China and Russia for tungsten, the state bank provided millions to Almonty Industries a few years ago. The mine in South Korea is nearing completion, prompting a revaluation of the stock. Rheinmetall's recent revaluation showcases the potential for significant stock price increases. Could Almonty be next? Meanwhile, JinkoSolar's stock took a notable hit yesterday, continuing its volatility. What lies ahead?
Read
Commented by Fabian Lorenz on October 24th, 2024 | 07:15 CEST
Buy recommendation for Nel ASA! Troubles at BYD! Globex Mining share has arrived in the gold rush!
The stock of Globex Mining has arrived in the gold and silver rush. Presented just four weeks ago as a candidate with catch-up potential, the stock of the mining incubator has since gained almost 30%. The chances of further price increases look promising. Meanwhile, the rush for hydrogen has largely dissipated. However, there is now a "Buy" recommendation for Nel ASA. Could the stock more than double? BYD, on its way to achieving a 5% market share in electric vehicles, is facing challenges! The Chinese, accustomed to success, are using this to step on the gas even more.
Read
Commented by Fabian Lorenz on October 23rd, 2024 | 07:30 CEST
More than 100% upside potential! Bayer, Plug Power and 123fahrschule – Which stock is convincing?
Analysts see more than a 100% upside potential in the 123fahrschule stock. The exciting second-line stock wants to make driver education more modern and efficient and is getting support from politicians. Accordingly, sales and profits should rise sharply. Plug Power can also show rising sales, but like industry colleague Nel, the Americans are unable to get a grip on their losses. Will the quarterly figures turn things around? Bayer shareholders have been waiting for a turnaround for quite some time. But analysts also expect falling profits in the coming quarterly report. Is there still potential for a 40% increase in the DAX share?
Read
Commented by Fabian Lorenz on October 17th, 2024 | 07:00 CEST
Big News for Nel, Evotec, and dynaCERT! Stock set for +100% or -20%?
Big news for Evotec. The analysts at Warburg see more than 100% upside potential. At the same time, however, they are warning of weak quarterly figures. Deutsche Bank even predicts a potential price drop. A long-awaited breakthrough came for dynaCERT. With VERRA's certification of HydraGEN products, trading in CO2 certificates is now possible, enabling new revenue opportunities for customers and dynaCERT. This could allow both dynaCERT and its stock to grow to a new level. At Nel, growth is slowing, and losses remain high. Is there any reason for hope?
Read
Commented by Fabian Lorenz on October 10th, 2024 | 07:00 CEST
50% profit margin? JinkoSolar, Nel ASA, and Desert Gold shares
A 50% profit margin? This is the prospect held out by the CEO of Desert Gold Ventures. The gold explorer aims to start production as early as next year. Even if the price of gold were to fall significantly, Desert would still be profitable. Or is a takeover perhaps on the cards? Unfortunately, Nel can only dream of such profit margins. The hydrogen specialist failed to establish a profitable business model during the boom phase. Now, orders are also drying up, and analysts are reducing the share price targets. And what is JinkoSolar doing? The Chinese company seems to be emerging as a winner from the solar crisis. However, even the market leader is feeling the effects of falling prices. Nevertheless, the share price has risen. Where is it worth entering?
Read
Commented by Fabian Lorenz on October 9th, 2024 | 07:15 CEST
Biotech comeback and takeover fantasy! BioNTech, Bayer, and Vidac Pharma
Money can be made in biotech shares again! However, investors need to look carefully. While Moderna is at a multi-year low, BioNTech and Vidac Pharma have gained over 50% in just a few months. Is there more to come? The chances are good, as both biotech companies have released promising news. Analysts see a tenfold increase in the case of Vidac Pharma, and the focus on the fight against cancer makes the Company a takeover candidate. The cancer specialist would also be a good fit for Bayer and BioNTech, and the share is still cheap. BioNTech is becoming an investment darling again and is focusing on AI. Bayer has yet to make the leap above EUR 30, and analysts are warning about the upcoming quarterly figures.
Read